The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Aripiprazole (Arpizol (5 mg)) is an atypical ...

Aripiprazole (Abilify, Bristol-Myers Squibb and Otsuka Pharmaceuticals) has a UK marketing authorisation for the treatment of schizophrenia in people aged 15 years and older. The initial marketing ...

Aripiprazole (Abilify, Otsuka Pharmaceuticals Europe) is an antipsychotic with partial dopamine D2 and D3 agonistic properties. It has a UK marketing authorisation 'for the treatment up to 12 weeks of ...

Pediatr Health. 2010;4(4):375-381. Aripiprazole is a partial agonist at the D 2 (dopamine) and 5-HT 1A (serotonin) receptors. It also functions as an antagonist at the 5-HT 2A receptor. Aripiprazole ...

Efficacy was maintained for the duration of the 24-hour study with IM aripiprazole 5 mg, 10 mg and 15 mg. Patients receiving IM haloperidol experienced significant reductions in PEC after 105 minutes ...

In addition, ABILIFY is available in a 1 mg/mL nonrefrigerated Oral Solution and as a single-dose, ready-to-use solution for intramuscular injection 7.5 mg/mL. In adult patients, the recommended ...

TOKYO, JAPAN and PRINCETON, NJ, Nov. 6, 2007 -- Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) approved ...

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd., announced today that the U.S. Food and Drug Administration (FDA) has approved ...

PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka America Pharmaceutical, Inc. (OAPI) and Lundbeck today announced that the U.S. Food and Drug Administration (FDA) has expanded the label of ...

Dr. Reddy’s Aripiprazole tablets 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg are available in bottle count sizes of 30. Hyderabad: Dr. Reddy’s Laboratories Ltd on Thursday announced that it has ...

Pediatr Health. 2010;4(4):375-381. In the retrospective study performed by Valicenti-McDermott and Demb, the mean BMI increased from 23.3 to 24. [17] The change was clinically significant for those ...